Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 11Phase 1 5Phase NA 3Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Head and Neck Neoplasms 4Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Medulloblastoma 2Fallopian Tube Neoplasms 2Tonsillar Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pinealoma 1Pharyngeal Neoplasms 1Pelvic Neoplasms 1Pancreatic Adenocarcinoma 1Ototoxicity 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Muscle Invasive Bladder Urothelial Carcinoma 1Mesothelioma, Malignant 1Lymphoma, B-Cell 1Liposarcoma 1Hepatoblastoma 1Esophageal Squamous Cell Carcinoma 1EGFR Positive Non-small Cell Lung Cancer 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1

Interventions

gallium Ga 68 dotatate 2etoposide phosphate 2Vincristine 2Thiotepa 2Temozolomide 2Mesna 2Magnetic Resonance Spectroscopy 2Etoposide 2Cyclophosphamide 2Carboplatin 23-Iodobenzylguanidine 2naxitamab 1fludarabine 1eliglustat 1Vaccines, DNA 1Topotecan 1Tamoxifen 1Rituximab 1Lenalidomide 1Isotretinoin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Ga(III)-DOTATOC 1Filgrastim 1Doxorubicin 1Cisplatin 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neuroblastoma × Cisplatin × Clear all
NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡